ACXP
Acurx·NASDAQ
--
--(--)
--
--(--)
ACXP Filings
Filing Date
Form Description
Form Type
2026-03-13
Acurx Pharmaceuticals, Inc. (ACXP) Q4 2025 Earnings Call Transcript
Earnings Call
2026-03-13 · Earnings Call
Acurx Pharmaceuticals, Inc. (ACXP) Q4 2025 Earnings Call Transcript
2026-03-12
Form S-8 - Securities to be offered to employees in employee benefit plans
Ownership
2026-03-12 · Ownership
Form S-8 - Securities to be offered to employees in employee benefit plans
2026-03-12
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-03-12 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-03-09
Form 8-K - Current report
Key Events
2026-03-09 · Key Events
Form 8-K - Current report
2026-02-12
Form EFFECT - Notice of Effectiveness
2026-02-12 ·
Form EFFECT - Notice of Effectiveness
2026-02-11
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-02-11 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-02-02
Form S-1 - General form for registration of securities under the Securities Act of 1933
2026-02-02 ·
Form S-1 - General form for registration of securities under the Securities Act of 1933
2026-01-07
Form EFFECT - Notice of Effectiveness
2026-01-07 ·
Form EFFECT - Notice of Effectiveness
2026-01-02
Form CORRESP - Correspondence
SEC Inquiries
2026-01-02 · SEC Inquiries
Form CORRESP - Correspondence
2025-12-30
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
2025-12-30 ·
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
